LG | Aksjer | 19,627 M | — | LG L&G | 0,49 | Helsevesen | Solactive Pharma Breakthrough Value Index | 23.1.2018 | 13,72 | 3,62 | 18,36 |
LG | Aksjer | 19,627 M | — | LG L&G | 0,49 | Helsevesen | Solactive Pharma Breakthrough Value Index | 23.1.2018 | 13,72 | 3,62 | 18,36 |
BO | Aksjer | 19,563 M | — | BO Bosera | 0,6 | Helsevesen | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 8.11.2022 | 0,52 | 0 | 0 |
TR | Aksjer | 18,526 M | 2 990,982 | TR T. Rowe Price | 0,44 | Helsevesen | | 11.6.2025 | 27,65 | 3,97 | 25,6 |
| Aksjer | 18,353 M | 2 359,577 | HK Horizon Kinetics | 0,85 | Helsevesen | | 30.1.2023 | 33,35 | 5,7 | 22,16 |
DI | Aksjer | 18,235 M | 119 403,6 | DI Direxion | 1,07 | Helsevesen | | 26.3.2025 | 19,99 | 0 | 0 |
PR | Aksjer | 16,159 M | 11 182,75 | PR Principal | 0,42 | Helsevesen | BTEC-US - No Underlying Index | 19.8.2016 | 39,41 | 4,34 | 0 |
BM | Aksjer | 15,752 M | — | BM BMO | 0 | Helsevesen | S&P Health Care Select Sector | 21.1.2025 | 28,2 | 0 | 0 |
IN | Aksjer | 15,19 M | — | IN Invesco | 0,18 | Helsevesen | S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care Index - Benchmark TR Net | 12.4.2023 | 6,21 | 4,97 | 23,13 |
HA | Aksjer | 14,625 M | — | HA HANetf | 0,59 | Helsevesen | Indxx Advanced Life Sciences & Smart Healthcare Thematic Index | 4.4.2019 | 7,33 | 9,44 | 30,16 |
HE | Aksjer | 14,459 M | — | HE Harvest ETFs | 1,06 | Helsevesen | | 27.2.2020 | 8,37 | 0 | 0 |
| Aksjer | 13,447 M | — | TA Tachlit | 0,5 | Helsevesen | S&P Health Care Select Sector | 13.11.2018 | 171,7 | 0 | 0 |
SP | Aksjer | 12,729 M | 10 560,29 | SP SPDR | 0,35 | Helsevesen | S&P Health Care Select Sector | 29.7.2025 | 24,57 | 0 | 0 |
EV | Aksjer | 12,406 M | — | EV Evolve | 0,72 | Helsevesen | Solactive Global Healthcare 20 Index - Benchmark TR Net | 27.11.2019 | 18,28 | 0 | 0 |
RO | Aksjer | 12,028 M | 5 559,98 | RO Roundhill | 0,99 | Helsevesen | | 3.12.2025 | 38,27 | 0 | 0 |
FT | Aksjer | 11,786 M | — | FT First Trust | 0,6 | Helsevesen | NYSE Arca Biotechnology Index | 27.5.2020 | 24,75 | 3,45 | 22,71 |
FT | Aksjer | 11,786 M | — | FT First Trust | 0,6 | Helsevesen | NYSE Arca Biotechnology Index | 27.5.2020 | 24,75 | 3,45 | 22,71 |
DI | Aksjer | 11,688 M | 106 486,3 | DI Direxion | 0,98 | Helsevesen | S&P Pharmaceuticals Select Industry | 15.11.2017 | 10,6 | 0 | 0 |
JP | Aksjer | 11,174 M | 926,002 | JP JPMorgan | 0,65 | Helsevesen | | 1.11.2023 | 55,58 | 4,96 | 22,26 |
| Aksjer | 10,994 M | — | TA Tachlit | 0,83 | Helsevesen | S&P Health Care Select Sector | 27.11.2018 | 43,73 | 0 | 0 |
VA | Aksjer | 10,606 M | — | VA VanEck | 0 | Helsevesen | MVIS Global Bionic Healthcare ESG Index - Benchmark TR Net | 2.12.2022 | 18,52 | 3,6 | 27 |
IS | Aksjer | 10,443 M | 3 865,578 | IS iShares | 0,55 | Helsevesen | | 29.9.2020 | 28,91 | 4,69 | 23,25 |
TE | Aksjer | 10,284 M | 107,375 | TE Tema | 0,75 | Helsevesen | | 22.1.2024 | 23,79 | 3,94 | 29,55 |
AM | Aksjer | 9,669 M | 2 195,5 | AM Amplify | 0,68 | Helsevesen | Prime Treatments, Testing and Advancements Index - USD | 17.6.2020 | 19,34 | 2,17 | 13,17 |
BM | Aksjer | 9,436 M | — | BM BMO | 0,4 | Helsevesen | Solactive Equal Weight U.S Health Care Index - CAD | 15.2.2019 | 41,68 | 3,68 | 20,81 |
HO | Aksjer | 9,257 M | — | HO Horizons | 1,63 | Helsevesen | North American Psychedelics Index - CAD | 26.1.2021 | 6,58 | 1,92 | 0 |
| Aksjer | 9,103 M | — | IT Itau | 0 | Helsevesen | Morningstar US Exponential Technologies Healthcare Index - Benchmark TR Gross | 9.6.2021 | 55,41 | 3,89 | 24,16 |
GX | Aksjer | 8,698 M | 2 907,795 | GX Global X | 0,65 | Helsevesen | MSCI China Health Care 10-50 | 7.12.2018 | 13,17 | 2,24 | 15,02 |
FI | Aksjer | 8,228 M | 1 896,422 | FI Fidelity | 0,4 | Helsevesen | Fidelity Digital Health Index | 5.10.2021 | 20,68 | 3,85 | 37,9 |
BM | Aksjer | 8,126 M | — | BM BMO | 0 | Helsevesen | | 26.6.2023 | 18,04 | 0 | 0 |
IN | Aksjer | 7,868 M | — | IN Invesco | 0,2 | Helsevesen | STOXX Europe 600 Optimised Health Care Index - EUR | 8.7.2009 | 397,47 | 3,5 | 20,5 |
DE | Aksjer | 7,483 M | 2 408,21 | DE Defiance | 0,45 | Helsevesen | NASDAQ Junior Biotechnology Index | 3.8.2020 | 29,93 | 5,24 | 0 |
| Aksjer | 7,267 M | — | IN Investo | 0 | Helsevesen | S&P Biotechnology Select Industry | 15.12.2021 | 59,86 | 0 | 0 |
| Aksjer | 6,946 M | 1 989,8 | RA Range | 0,79 | Helsevesen | Range Oncology Therapeutics Index | 13.10.2015 | 8,9 | 1,22 | 0 |
FT | Aksjer | 6,186 M | — | FT First Trust | 0,8 | Helsevesen | StrataQuant Health Care Index | 29.10.2014 | 41,32 | 3,02 | 17,23 |
IS | Aksjer | 6,174 M | — | IS iShares | 0,47 | Helsevesen | NYSE FactSet Global Genomics and Immuno Biopharma Index | 26.4.2022 | 40,42 | 2,86 | 14,62 |
| Aksjer | 5,075 M | — | MU Mulvihill | 0 | Helsevesen | | 31.1.2023 | 7,73 | 4,06 | 25,89 |
DE | Aksjer | 5,042 M | 6 192,89 | DE Defiance | 0,75 | Helsevesen | | 27.5.2021 | 5,93 | 0 | 0 |
IS | Aksjer | 4,993 M | 1 153,047 | IS iShares | 0,47 | Helsevesen | NYSE FactSet Global Neuro Biopharma and MedTech Index | 24.8.2022 | 33,22 | 4,64 | 16,48 |
GX | Aksjer | 4,909 M | — | GX Global X | 1,2 | Helsevesen | Solactive Telemedicine & Digital Health Index- TR Net | 17.12.2020 | 7,54 | 3,22 | 29,6 |
| Aksjer | 4,664 M | — | CI CIRCA5000 | 0,49 | Helsevesen | Impak CIRCA5000 Health & Wellbeing Impact Index - Benchmark TR Net | 5.6.2023 | 5,22 | 0 | 0 |
BM | Aksjer | 4,357 M | — | BM BMO | 0 | Helsevesen | S&P Health Care Select Sector | 21.1.2025 | 28,54 | 0 | 0 |
HE | Aksjer | 4,343 M | — | HE Harvest ETFs | 0 | Helsevesen | | 21.8.2024 | 8,09 | 0 | 0 |
CI | Aksjer | 4,299 M | — | CI CI | 0,84 | Helsevesen | | 7.6.2018 | 12,29 | 0 | 0 |
AM | Aksjer | 4,172 M | 3 176,789 | AM Amplify | 0,59 | Helsevesen | VettaFi Weight Loss Drug & Treatment Index - Benchmark TR Net | 21.5.2024 | 24,07 | 5,28 | 19,73 |
| Aksjer | 4,161 M | — | KS KSM | 0 | Helsevesen | STOXX Europe 600 / Health Care (Capped) - SS | 20.11.2018 | 429,28 | 0 | 0 |
| Aksjer | 4,026 M | 470,644 | LO Loncar | 0,79 | Helsevesen | Loncar China BioPharma | 14.8.2018 | 14,88 | 1,73 | 12,13 |
PR | Aksjer | 3,998 M | 14 883,49 | PR ProShares | 0,95 | Helsevesen | S&P Health Care Select Sector | 30.1.2007 | 10,59 | 0 | 0 |
AN | Aksjer | 3,983 M | 9 586,47 | AN Anfield | 0,95 | Helsevesen | MarketGrader Global Health Care Leaders Index | 21.9.2021 | 8,91 | 4 | 12,63 |
HE | Aksjer | 3,959 M | — | HE Harvest ETFs | 0 | Helsevesen | | 15.1.2026 | 6,46 | 0 | 0 |
TR | Aksjer | 3,958 M | 35 128,46 | TR Tradr | 1,3 | Helsevesen | | 22.10.2025 | 10,41 | 0 | 0 |
FT | Aksjer | 3,885 M | — | FT First Trust | 0,73 | Helsevesen | NYSE Arca Biotechnology Index | 17.2.2021 | 35,32 | 28,29 | 30,59 |
| Aksjer | 3,856 M | 6 199,706 | AD ADRhedged | 0,19 | Helsevesen | | 7.1.2025 | 20,68 | 0 | 0 |
GR | Aksjer | 3,807 M | — | GR GraniteShares | 5,2 | Helsevesen | Solactive Daily Leveraged 3x long Moderna Index - Benchmark TR Net | 30.8.2021 | 39,83 | 0 | 0 |
RS | Aksjer | 3,795 M | 8 022,96 | RS REX Shares | 0,99 | Helsevesen | | 4.11.2025 | 22,05 | 0 | 0 |
| Aksjer | 3,475 M | 2 123,553 | LA Langar | 0,85 | Helsevesen | | 10.1.2024 | 8,63 | 3,48 | 25,34 |
TD | Aksjer | 3,458 M | — | TD TD | 0,45 | Helsevesen | Solactive Global Healthcare Leaders Index | 2.5.2022 | 13,66 | 0 | 0 |
GX | Aksjer | 3,436 M | 643,568 | GX Global X | 0,6 | Helsevesen | Cboe S&P Health Care Select Sector Half BuyWrite Index - Benchmark TR Gross | 21.11.2022 | 24,54 | 5,04 | 27,46 |
DI | Aksjer | 3,052 M | 743,824 | DI Direxion | 0,98 | Helsevesen | NYSE Biotechnology Top 5 Equal Weight Index - Benchmark TR Gross | 1.10.2025 | 29,23 | 0 | 0 |
DI | Aksjer | 3,019 M | 2 823,156 | DI Direxion | 0,65 | Helsevesen | BITA Messenger RNA Technology Index - Benchmark TR Net | 9.12.2021 | 13,76 | 3,69 | 0 |
GR | Aksjer | 2,928 M | 6 209,94 | GR GraniteShares | 1,5 | Helsevesen | | 7.10.2025 | 23,07 | 0 | 0 |
FI | Aksjer | 2,893 M | — | FI Fidelity | 0,5 | Helsevesen | Fidelity Digital Health ESG Tilted Index - Benchmark TR Net | 24.8.2022 | 5,42 | 0 | 0 |
FT | Aksjer | 2,882 M | — | FT First Trust | 0,82 | Helsevesen | StrataQuant Health Care Index - CAD | 8.12.2017 | 28,81 | 0 | 0 |
DI | Aksjer | 2,838 M | 17 809,32 | DI Direxion | 1,01 | Helsevesen | Eli Lilly and Co. - USD - Benchmark Price Return | 26.3.2025 | 19,31 | 0 | 0 |
| Aksjer | 2,778 M | — | TA Tachlit | 0,3 | Helsevesen | NASDAQ / Biotechnology | 27.11.2018 | 30,55 | 0 | 0 |
DE | Aksjer | 2,745 M | 39 400,93 | DE Defiance | 1,51 | Helsevesen | | 18.8.2025 | 5,17 | 0 | 0 |
GX | Aksjer | 2,712 M | — | GX Global X | 0 | Helsevesen | VettaFi Equal Weight Global Healthcare Index - CAD - Benchmark TR Net | 30.4.2025 | 21,64 | 0 | 0 |
FR | Aksjer | 2,628 M | — | FR Franklin | 0,3 | Helsevesen | Solactive Sustainable Health and Wellness Index | 5.7.2023 | 27,13 | 3,22 | 18,08 |
FR | Aksjer | 2,628 M | — | FR Franklin | 0,3 | Helsevesen | Solactive Sustainable Health and Wellness Index | 5.7.2023 | 27,13 | 3,22 | 18,08 |
FR | Aksjer | 2,628 M | — | FR Franklin | 0,3 | Helsevesen | Solactive Sustainable Health and Wellness Index | 5.7.2023 | 27,13 | 3,22 | 18,08 |
FT | Aksjer | 2,449 M | 381,932 | FT First Trust | 0,65 | Helsevesen | NASDAQ Lux Health Tech Index | 22.3.2022 | 16,35 | 4,66 | 26,17 |
PR | Aksjer | 2,446 M | 14 809,44 | PR ProShares | 0,95 | Helsevesen | NASDAQ / Biotechnology | 7.4.2010 | 8,77 | 0 | 0 |
CI | Aksjer | 2,325 M | — | CI CI | 0,85 | Helsevesen | | 3.3.2022 | 9,28 | 0 | 0 |
| Aksjer | 2,101 M | 2 437,822 | KE Kelly | 0,78 | Helsevesen | Strategic CRISPR & Gene Editing Technology Index - Benchmark TR Gross | 12.1.2022 | 7,02 | 1,68 | 17,02 |
HO | Aksjer | 2,033 M | — | HO Horizons | 1,19 | Helsevesen | Solactive Global Vaccines and Infectious Diseases Index - CAD - Benchmark TR Net | 26.10.2021 | 15,47 | 0 | 0 |
HE | Aksjer | 2,028 M | — | HE Harvest ETFs | 0 | Helsevesen | | 15.1.2026 | 13,49 | 0 | 0 |
LS | Aksjer | 1,97 M | — | LS Leverage Shares | 3,78 | Helsevesen | iSTOXX Leveraged 3x MRNA Index - Benchmark TR Net | 14.12.2021 | 18,28 | 0 | 0 |
KR | Aksjer | 1,965 M | 1 458,156 | KR KraneShares | 0,81 | Helsevesen | Solactive Emerging Markets Healthcare Index NTR | 29.8.2018 | 19,78 | 3,09 | 26,95 |
PU | Aksjer | 1,926 M | — | PU Purpose | 1,27 | Helsevesen | | 4.10.2021 | 19,26 | 4,48 | 18,17 |
FT | Aksjer | 1,912 M | 174,001 | FT First Trust | 0,7 | Helsevesen | Indxx Global Medical Equipment Index | 22.6.2021 | 19,07 | 2,93 | 26,01 |
| Aksjer | 1,904 M | 994,956 | PS PSYK | 0,75 | Helsevesen | Enhanced Consciousness Index - Benchmark TR Net | 31.1.2022 | 17,31 | 2,18 | 0 |
GX | Aksjer | 1,733 M | 1 413,659 | GX Global X | 0,65 | Helsevesen | Solactive China Biotech Innovation Index | 22.9.2020 | 7,51 | 2,41 | 18,61 |
BE | Aksjer | 1,683 M | — | BE BetaShares | 0,67 | Helsevesen | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net | 30.3.2022 | 10,54 | 3,36 | 39,43 |
KR | Aksjer | 1,497 M | — | KR KraneShares | 0,65 | Helsevesen | MSCI China All Shares Health Care 10/40 Index | 14.1.2021 | 9,98 | 2,55 | 19 |
DE | Aksjer | 1,476 M | 84 832,41 | DE Defiance | 1,29 | Helsevesen | | 2.9.2025 | 8,55 | 0 | 0 |
HE | Aksjer | 1,37 M | — | HE Harvest ETFs | 0 | Helsevesen | | 21.8.2024 | 8,98 | 0 | 0 |
| Aksjer | 1,098 M | 6 395,882 | AD ADRhedged | 0,19 | Helsevesen | AstraZeneca PLC - Benchmark Price Return | 1.10.2024 | 54,92 | 0 | 0 |
HO | Aksjer | 1,098 M | — | HO Horizons | 0,89 | Helsevesen | Solactive Telemedicine & Digital Health Index- TR Net | 2.11.2021 | 18,3 | 0 | 0 |
BM | Aksjer | 1,091 M | — | BM BMO | 0 | Helsevesen | | 9.2.2026 | 42,86 | 0 | 0 |
DE | Aksjer | 1,019 M | 12 108,85 | DE Defiance | 1,31 | Helsevesen | | 3.2.2026 | 24,56 | 0 | 0 |
BR | Aksjer | 962 707,75 | — | BR Brompton | 1,09 | Helsevesen | | 8.8.2019 | 11,66 | 0 | 0 |
AI | Aksjer | 865 180,5 | 356,089 | AI AXS Investments | 1,15 | Helsevesen | Pfizer Inc. | 14.7.2022 | 58,55 | 0 | 0 |
GR | Aksjer | 845 907,7 | 7 032,454 | GR GraniteShares | 1,07 | Helsevesen | | 2.12.2025 | 7,45 | 0 | 0 |
| Aksjer | 789 078,9 | 440,677 | AD ADRhedged | 0,19 | Helsevesen | GSK plc - Benchmark Price Return | 7.1.2025 | 80,36 | 0 | 0 |
GR | Aksjer | 706 216,1 | — | GR GraniteShares | 0,99 | Helsevesen | Solactive Daily Leveraged 3x short Moderna Index - EUR - Benchmark TR Net | 30.8.2021 | 3,76 | 0 | 0 |
GR | Aksjer | 656 690,2 | — | GR GraniteShares | 2,39 | Helsevesen | Solactive Daily Leveraged 3x long BP Index | 4.11.2019 | 53,47 | 0 | 0 |
LS | Aksjer | 654 524 | 3 930,099 | LS Leverage Shares | 0,75 | Helsevesen | | 18.12.2025 | 10,74 | 0 | 0 |
| Aksjer | 603 747,5 | 286,644 | SU Subversive | 0,76 | Helsevesen | | 23.12.2022 | 24,15 | 4,55 | 28,5 |
| Aksjer | 585 416 | 654,364 | WE WEBs | 0,89 | Helsevesen | Syntax Defined Volatility XLV Index - Benchmark TR Net | 23.7.2025 | 29,05 | 0 | 0 |
LS | Aksjer | 523 454,53 | — | LS Leverage Shares | 0 | Helsevesen | Euronext 3x Long UnitedHealth Index - Benchmark TR Net | 16.9.2025 | 6,65 | 0 | 0 |